low end, tjx. tjx is rock solid. did a lot of work on it today. dow down 268. you' got to use the pain of the hedge funds that created this to get the gain for you. it doesn't happen overnight. we buy on scales. want to buy 200 shares of a stock marked down. tomorrow you buy 50. our gain, their loss. "mad money" back after the break. >>> coming up, cosmetic cash? could a botox boom held this company ride the recovery? cramer is talking to allergan's ceo to find out. and later, all eyes on tech. can the semiconductors continue to connect your portfolio with profits? cramer is going one-on-one with novellus' ceo on "the executive decision." plus, natural trash? could this company turn trash into cash? kramer is going head to head with the coo to find out. all coming up on "mad money". ma? yes, i hear progressive has lots of discounts on car insurance. can i get in on that? are you a safe driver? yes. discount! do you own a home? yes. discount! are you going to buy online? yes! discount! isn't getting discounts great? yes! there's no discount for agreeing with me.

low end, tjx. did a lot of work on it today. dow down 268. you' got to use the pain of the hedge funds that created this to get the gain for you. it doesn't happen overnight. we buy on stale skails. want to buy 200 shiefrs a stock marked down. tomorrow you buy 50. our gain, their loss. "mad money" back after the break. >>> coming up, cosmetic cash? could a botox boom held this company ride the recovery? cramer is talking to allergan's ceo to find out. and later, all eyes on tech. can the semiconductors continue to connect your portfolio with profits? cramer is going one-on-one with novellus' ceo on "the executive decision." plus, natural sflash coutrash? could this company turn trash into cash?  >> i don't know, could it really be -- oh we're down 260 today. i shouldn't be focused on botox. i like to look at companies whose stocks were able to go higher. can you imagine how good they are? they can get some lift in spite of the hair-trigger selling. and you know what? today you lost money if you own gold, oil, you lost mo

three names in particular i want to touch on, tjx, touching on an all-time high. kohl's really good numbers and they're gaining despite some tepid guidance so that's going to tell you something. and limited touched a two-year high despite that weather looking very good in terms of comp sales. now you usual lie don't talk about hyatt and heinz in the same. why am i mentioning them together? well, they both came out and said their overseas' business is better than their u.s. business. so if you're looking at outlie ars take a look at that one and end on health care. we talked about the health care summit today take a look at some of the hmo names, humana, signa, unitedhealth, three in particular. they're not moving a whole lot. what's the takeaway from an investor's standpoint? well, not much action coming out of d.c. right now when it comes to health care, at least in terms of what we're hearing today. let's hear about the tech sector and what we're hearing today from bertha coombs at the nasdaq. >> reporter: thanks, brian. you know sometimes, it's the analysts get

tjx beat on the bottom, a little light on the top. the guidance on the high side of expectations. buying back shares. they're hiking their difficult denld. i also want to tuch ouch on alt returning 35 cents a share to its share holders. let's go to bertha coombs. >> we're starting off up about 11 points or so. we've been in such a tight trading range the last few days. right now auto desk among those really boosting the big caps posting better than expected earnings and earning an upgrade over at needham and company. dollar tree also posting better earnings and boosting its outlook above expectations. it sees earnings of 70 to 80 cents. google this morning, lots of headlines out of europe. three executives were convicted in a privacy case involving youtube in italy and the eu also looking into antitrust complaints against google. as you get bigger the regulatory complaints get bigger as well. had hoped to have salex pharma here, a biotech yesterday that was halted all day starting the day up about 17% after the fda panel recommended its drug to treat a liver disease. stec is the o